These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

137 related items for PubMed ID: 11925520

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Practice parameter for use of electroconvulsive therapy with adolescents.
    Ghaziuddin N, Kutcher SP, Knapp P, Bernet W, Arnold V, Beitchman J, Benson RS, Bukstein O, Kinlan J, McClellan J, Rue D, Shaw JA, Stock S, Kroeger Ptakowski K, Work Group on Quality Issues, AACAP.
    J Am Acad Child Adolesc Psychiatry; 2004 Dec; 43(12):1521-39. PubMed ID: 15564821
    [Abstract] [Full Text] [Related]

  • 25. Consensus conference. Electroconvulsive therapy.
    JAMA; 1985 Oct 18; 254(15):2103-8. PubMed ID: 4046138
    [Abstract] [Full Text] [Related]

  • 26. Predictors of Electroconvulsive Therapy Use in a Large Inpatient Psychiatry Population.
    Knight J, Jantzi M, Hirdes J, Rabinowitz T.
    J ECT; 2018 Mar 18; 34(1):35-39. PubMed ID: 29023285
    [Abstract] [Full Text] [Related]

  • 27. Electroconvulsive therapy in patients with epilepsy.
    Lunde ME, Lee EK, Rasmussen KG.
    Epilepsy Behav; 2006 Sep 18; 9(2):355-9. PubMed ID: 16876485
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Maintenance ECT as a therapeutic approach to medication-refractory epilepsy in an adult with mental retardation: case report and review of literature.
    Shah N, Pande N, Bhat T, Murke M, Andrade C.
    J ECT; 2012 Jun 18; 28(2):136-40. PubMed ID: 22531207
    [Abstract] [Full Text] [Related]

  • 30. [Family Burden in the Case of Intellectual Disability and a Comorbid Mental Disorder].
    Werner A, Voß E, Salize HJ, Puschner B, Stiawa M, Koch A, Schützwohl M.
    Psychiatr Prax; 2016 Oct 18; 43(7):380-386. PubMed ID: 26488265
    [Abstract] [Full Text] [Related]

  • 31. Electroconvulsive therapy for affective disorders in persons with mental retardation.
    Kessler RJ.
    Psychiatr Q; 2004 Oct 18; 75(1):99-104. PubMed ID: 14992306
    [Abstract] [Full Text] [Related]

  • 32. The use of ECT in intellectual disability.
    Cutajar P, Wilson D.
    J Intellect Disabil Res; 1999 Oct 18; 43 ( Pt 5)():421-7. PubMed ID: 10546967
    [Abstract] [Full Text] [Related]

  • 33. Integrating behavioral and pharmacological interventions in treating clients with psychiatric disorders and mental retardation.
    Sevin JA, Bowers-Stephens C, Hamilton ML, Ford A.
    Res Dev Disabil; 2001 Oct 18; 22(6):463-85. PubMed ID: 11768671
    [Abstract] [Full Text] [Related]

  • 34. Cognitive-behavioral therapy. Treating individuals with dual diagnoses.
    Romana MS.
    J Psychosoc Nurs Ment Health Serv; 2003 Dec 18; 41(12):30-5. PubMed ID: 14682029
    [Abstract] [Full Text] [Related]

  • 35. [The use of electroconvulsive therapy in acute services at the general hospital].
    Castel B, Chamorro L, Olivares D, Huertas D.
    Actas Esp Psiquiatr; 2000 Dec 18; 28(2):88-95. PubMed ID: 10937389
    [Abstract] [Full Text] [Related]

  • 36. [Electroconvulsive therapy in neurologic diseases].
    Folkerts H.
    Nervenarzt; 1995 Apr 18; 66(4):241-51. PubMed ID: 7783810
    [Abstract] [Full Text] [Related]

  • 37. Experience, Knowledge, and Attitudes of Child and Adolescent Psychiatrists in Belgium Toward Pediatric Electroconvulsive Therapy.
    De Meulenaere M, De Meulenaere J, Ghaziuddin N, Sienaert P.
    J ECT; 2018 Dec 18; 34(4):247-252. PubMed ID: 29465501
    [Abstract] [Full Text] [Related]

  • 38. Effectiveness of electroconvulsive therapy in community settings.
    Prudic J, Olfson M, Marcus SC, Fuller RB, Sackeim HA.
    Biol Psychiatry; 2004 Feb 01; 55(3):301-12. PubMed ID: 14744473
    [Abstract] [Full Text] [Related]

  • 39. Retrospective evaluation of the dexamethasone suppression test as a predictor of response to electroconvulsive therapy in patients with comorbid major depressive disorder and posttraumatic stress disorder.
    Watts BV, Groft A.
    J ECT; 2010 Sep 01; 26(3):213-7. PubMed ID: 20386115
    [Abstract] [Full Text] [Related]

  • 40. Epidemiologic considerations in electroconvulsive therapy.
    Babigian HM, Guttmacher LB.
    Arch Gen Psychiatry; 1984 Mar 01; 41(3):246-53. PubMed ID: 6703844
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.